Sugammadex: all 201 studies that test it

Page 2 of 3. Open to participants first (15), then studies with results posted, then the rest; newest registration first within each.

• Neostigmine Versus Sugammadex on Renal FunctionsActive, not recruitingNCT06081738Phase 4
• The Occurrence of Emergence Agitation in Pediatric Strabismus SurgeryCompletedNCT06035757Phase 4
• The Impact of Sugammadex on Ileus After Abdominal Wall ReconstructionCompletedNCT05985343Phase 4
• Postoperative Sugammadex After COVID-19Status unknownNCT05817019Phase 4
• Diaphragm Function After Reversal of Rocuronium-induced Neuromuscular Blockade With Sugammadex or Neostigmine in ChildrenCompletedNCT05724550Not applicable
• The Immunomodulatory Effect of Sugammadex After Total Hip Replacement Surgery Under Neuraxial Anaesthesia: a Pilot StudyCompletedNCT05723406Phase 2
• Low Dose of Sugammadex vs Neostigmine and Glycopyrrolate for the Reversal of RocuroniumCompletedNCT05718934Phase 4
• The Role of Sugammadex in Posotoperative Urinary Retention in Patients Undergoing Pelvic Floor Reconstructive ProceduresWithdrawnNCT05664633Phase 1/2
• Clinical Application Value of Remazolam Combined With Sugammadex Sodium in Anesthesia for Endotracheal Surgery Under BronchoscopyCompletedNCT05468671Phase 4
• Perioperative Respiratory Adverse events_sugammadexCompletedNCT05354466Phase 4
• Pharmacokinetics and Pharmacodynamics of Sugammadex Dosed by Corrected Body Weight for Reversal of Vecuronium in Obese PatientsCompletedNCT05328778Phase 4
• Sugammadex and Smoker's Neuromuscular BlockCompletedNCT05313100Phase 4
• Effect of Sugammadex for Reversal of Rocuronium-induced Neuromuscular Block on Perioperative Management of Awake CraniotomyStatus unknownNCT05202899Phase 4
• Pharmacokinetics of Sugammadex for the Reversal of Moderate Neuromuscular Blockade in Patients During Renal TransplantationStatus unknownNCT05187455Phase 4
• Residual Paralysis and Reversal With Routine Neostigmine Versus Half-dose Sugammadex and Routine NeostigmineCompletedNCT05066035Phase 4
• Diaphragm Ultrasound to Evaluate the Antagonistic Effect of SugammadexStatus unknownNCT05028088Phase 4
• Comparative Efficacy and Safety of Sugammadex and NeostigmineStatus unknownNCT04997759Not applicable
• The Feasibility of Sugammadex for General Anesthesia in Patients Undergoing Kidney and Pancreas Transplantation SurgeryCompletedNCT04944303Not applicable
• Recovery From dNMB Using Different Sugammadex Doses in Elderly Patients Undergoing Robot-assisted ProstatectomyCompletedNCT04854993Phase 3
• Reversal of Neuromuscular Blockade and Perioperative ArrhythmiasCompletedNCT04720573Not applicable
• Effect of Muscle Relaxation Reversal on the Success Rate of Motor Evoked Potential RecordingCompletedNCT04608682Not applicable
• Effectiveness of Sugammadex on Muscle Relaxant Reversal in Preterm NeonatesStatus unknownNCT04566796Not applicable
• A Pharmacokinetic Study of Sugammadex in Dialysis PatientsWithdrawnNCT04556721Phase 1
• Comparison of the Impacts of Sugammadex With Neostigmine on Patency of Laryngeal Opening (Glottic Aperture Angle)Status unknownNCT04545099Not applicable
• The Effect of Sugammadex During Transcranial Electrical Motor Evoked Potential Monitoring in Spinal SurgeryCompletedNCT04471376Not applicable
• Sugammadex on Remifentanil Ce for Preventing Emergence Cough in FemaleCompletedNCT04407078Not applicable
• Pharmacokinetic-pharmacodynamic Analysis of Sugammadex for Conventional Reversal in ChildrenCompletedNCT04347486Phase 2
• Comparison of QoR-15 in Laparoscopic Cholecystectomy: Sugammadex vs. NeostigmineCompletedNCT04332627Phase 4
• Sugammadex Versus Neostigmine in Pediatric Less Than Two Years Undergoing Cardiac CatheterizationCompletedNCT04258007Not applicable
• Deep vs Moderate Neuromuscular Blocks on Remifentanil for Laparoscopic GastrectomyCompletedNCT04205097Not applicable
• Enhanced Recovery After Surgery for Anterior Cervcial Spine Surgeries in Elderly PatientsStatus unknownNCT04161508Not applicable
• Pharmacokinetics and Pharmacodynamics of Sugammadex in Reversal of Vecuronium-induced Neuromuscular BlockadeStatus unknownNCT04131218Phase 4
• Different Reversal Agents in Pediatric Day-case Cancer SurgeryStatus unknownNCT03996655Phase 4
• Efficacy and Safety of Sugammadex in High-Risk Ambulatory SurgeriesWithdrawnNCT03944473Phase 4
• The Improvement of Intraoperative Neuromonitoring of Recurrent Laryngeal NerveCompletedNCT03911232Not applicable
• Deep Neuromuscular Relaxation Optimizing Low-Pressure Bariatric SurgeryStatus unknownNCT03803982Not applicable
• Effect of Rocuronium and Sugammadex Under Sevoflurane and Desflurane Anesthesia in ChildrenCompletedNCT03795259Not applicable
• The Use of Sugammadex in the Critically IllStatus unknownNCT03791801Not applicable
• the Efficacy and Safety of Sugammadex in Children 0-2 Years OldStatus unknownNCT03728543Phase 2/3
• Adequate Dosage of Sugammadex on Thyroid SurgeryCompletedNCT03689413Not applicable
• Sugammadex on Remifentanil Ce for Preventing Emergence Cough in MaleCompletedNCT03583021Not applicable
• Residual Neuromuscular Blockade in Cardiac Surgery PatientsWithdrawnNCT03574337Phase 4
• Role of Curarization During Anesthesia for Gynecologic Surgical Laparotomy ProceduresStatus unknownNCT03519724Phase 2
• Role of Curarization During Anesthesia for Laparoscopic HysterectomyCompletedNCT03519633Phase 2
• Minimal Optimal Dose of Sugammadex in Elective SurgeryCompletedNCT03515694Phase 4
• Comparison of Reversal of Neuromuscular Blockade With Sugammadex Versus Neostigmine Plus Glycopyrolate in Patients Undergoing Burn SurgeryCompletedNCT03513406Phase 3
• Reversal With Low Doses of Sugammadex in Patients Undergoing Non-cardiac SurgeryStatus unknownNCT03460509Phase 4
• Deep Neuromuscular Block During General Anaesthesia in Robotic SurgeryCompletedNCT03420937Phase 4
• The Effect of Sugammadex Given Based on Ideal, Actual or Adjusted Body Weight on Reversal of Rocuronium.CompletedNCT03381209Not applicable
• Effect of NMBA on Surgical Conditions in THRWithdrawnNCT03369782Phase 4
• Combined Use of Low-dose Sugammadex Plus Neostigmine Administered for Reversal of RocuroniumStatus unknownNCT03328312Early Phase 1
• Monitoring of Postoperative Residual Neuromuscular Blockade in Laparoscopic SurgeryCompletedNCT03292965Not applicable
• GA/Spinal vs. GA/Spinal/NMB for Operative Repair of Hip FractureWithdrawnNCT03226080Phase 4
• Recovery From Anesthesia After Robotic Assisted Radical CystectomyStatus unknownNCT03144453Phase 4
• Comparing Reversal With Neostigmine and Sugammadex in PaediatricCompletedNCT03137290Not applicable
• Comparison the Postoperative Quality of Recovery Between Neostigmine and Sugammadex in Elderly Patients Undergoing Trans Pars Plana Vitrectomy With General Anesthesia -Randomized Controlled Trial-CompletedNCT03108989Not applicable
• Cerebral Oxygenation and Metabolism After Reversal Of Rocuronium: Comparison Between Sugammadex Versus NeostigmineStatus unknownNCT02944175Not applicable
• Sugammadex Reversal of Neuromuscular Blockade and Postoperative BleedingStatus unknownNCT02939430Not applicable
• Surgical Conditions During Vocal Cord Surgery Requiring Jet Ventilation With Moderate vs. Deep Neuromuscular BlockTerminatedNCT02888067Phase 1
• Prevention of Postoperative Events Following Reversal With Sugammadex or NeostigmineTerminatedNCT02825576Phase 4
• Sugammadex Given for the Reversal of Rocuronium Induced Neuromuscular Blockade Under Sevoflurane Anesthesia in InfantsCompletedNCT02708056Phase 4
• Recovery of Muscle Function After Deep Neuromuscular Block by Means of Diaphragm UltrasonographyStatus unknownNCT02698969Phase 4
• Sugammadex/Neostigmine and Liver TransplantationCompletedNCT02697929Not applicable
• Sugammadex Versus Neostigmine for Postoperative Nausea and Vomiting After Laparoscopic Gynaecological SurgeryCompletedNCT02666014Phase 3
• Sugammadex Dosage Based on Ideal Body Weight for Profound Rocuronium-induced Neuromuscular Blockade Reversal in Morbidly Obese PatientsCompletedNCT02545595Phase 2
• Deep Neuromuscular Blockade During Robotic Radical ProstatectomyStatus unknownNCT02513693Phase 4
• Neuromuscular Blockade Reversal Agent Effect on Postoperative Cognitive Function and Behaviour in ChildrenCompletedNCT02455921Phase 4
• Quality of Awakening and Impact on Cognitive Function After Administration of Sugammadex in Robotic Radical CystectomyCompletedNCT02454504Not applicable
• Sugammadex and Cognitive FunctionCompletedNCT02419352Not applicable
• Sugammadex Versus Neostigmine in Patients With Liver Cirrhosis Undergoing Liver ResectionCompletedNCT02414880Phase 4
• Rocuronium + Sugammadex vs. Succinylcholine + Cisatracurium + Neostigmine/Atropine in Obese Participants (MK-8616-104)WithdrawnNCT02410590Phase 4
• Effect of Sugammadex for Muscle Motor Response and Awareness in Intraoperative WakeupCompletedNCT02390817Phase 4
• Effects of Neuromuscular Block Reversal With Sugammadex vs Neostigmine on Postoperative Respiratory Outcomes After Major Abdominal SurgeryCompletedNCT02361060Phase 4
• Comparison of the Effects of Neostigmine With Sugammadex on Postoperative Nausea and Vomiting.CompletedNCT02286752Phase 4
• Functional Respiratory Imaging After Neostigmine or SugammadexCompletedNCT02284412Phase 4
• A Randomized Double Blind Controlled Trial Comparing Sugammadex and Neostigmine After Thoracic AnesthesiaTerminatedNCT02256280Phase 4
• Intraocular Pressure Changes Associated With Tracheal Extubation: Comparison of Sugammadex With Conventional Reversal of Neuromuscular BlockadeCompletedNCT02215382Phase 4
• Sugammadex Compared With Neostigmin/Atropin for Neuromuscular Block Reversal in Patients With Obstructive Sleep ApneaCompletedNCT02160223Phase 4
• A Pilot Study Using Rocuronium to Prevent Intermediate Syndrome After Organophosphorus Insecticide PoisoningCompletedNCT02147054Phase 2/3
• Validation of Subjective Rating Scales Used to Assess Surgical Conditions in Abdominal SurgeryCompletedNCT02079337Phase 4
• Dose Finding Study for Effective Reversal of a Deep Rocuronium-induced Neuromuscular Block With Sugammadex in Morbidly Obese PatientsCompletedNCT01911520Phase 2
• Muscle Relaxation for Short ProceduresCompletedNCT01902641Not applicable
• The Dose of Sugammadex for Rapid Reversal of Profound Neuromuscular Block in Young and Elderly PatientsCompletedNCT01890057Not applicable
• Pilot Study on the Pharmacodynamics of Sugammadex in Morbidly Obese Patients: Reversal of Deep Neuromuscular BlockadeStatus unknownNCT01855217Phase 3
• Reversal With Sugammadex From Deep Neuromuscular Blockade Induced by Rocuronium in Children: Randomised Clinical TrialCompletedNCT01809886Phase 3
• Efficacy and Safety of Sugammadex in Renal Diseased PatientsCompletedNCT01785758Phase 4
• Modern Myorelaxation Procedure and Reversal of Neuromuscular Blockade With General Anesthesia for Caesarean SectionCompletedNCT01718236Phase 4
• Comparative Study of Sugammadex Versus Neostigmine for Reversal of Neuromuscular Blockade in Morbidly Obese PatientsStatus unknownNCT01629394Phase 2/3
• Recovery After Sugammadex(Propofol vs Sevoflurane)CompletedNCT01579851Phase 4
• Optimal Relaxation Technique for Laparotomies With Rocuronium Infusion Followed by Sugammadex ReversalCompletedNCT01539044Phase 4
• Sugammadex and Heart FailureCompletedNCT01509651Phase 3
• Evaluation of Accelerometer-Based Neuromuscular Monitoring Reliability to Exclude Postoperative Residual ParalysisCompletedNCT01503840Not applicable
• Street Fitness in Surgical Patients Undergoing General Anesthesia After Reversal of Neuromuscular BlockadeStatus unknownNCT01453530Phase 4
• Sugammadex Efficacy and Safety for Reversal of Pipecuronium-induced Neuromuscular BlockadeStatus unknownNCT01424488Phase 4
• Sugammadex: Effect on the Awareness Monitoring and HemodynamicsStatus unknownNCT01301261Not applicable
• Sugammadex and Brain WavesCompletedNCT01142648Phase 4
• Sugammadex Improves Muscle Function After Standard Neuromuscular RecoveryCompletedNCT01101139Phase 4
• Efficacy, Pharmacokinetics and Safety of Org 25969 in Subjects With Normal or Impaired Renal Function (19.4.304)(P05948)(COMPLETED)CompletedNCT00482599Phase 3
• Comparison of Rocuronium and Org 25969 With Cisatracurium and Neostigmine (19.4.310)(P05931)CompletedNCT00451100Phase 3
• Safety and Efficacy Evaluation of Sugammadex in Cardiac Patients (19.4.309)(P05934)CompletedNCT00420680Phase 3

← Sugammadex overview